High-Level Group on Scientific Advice

High-Level Group on Scientific Advice is an advisory body established to strengthen the role of science policy input into European Commission decision-making, linking scientific expertise and policymaking across the European Union, European Parliament, Council of the European Union, and international stakeholders. It operated alongside institutions such as the Joint Research Centre, the European Research Council, the European Science Foundation, and external networks including the Organisation for Economic Co-operation and Development, the World Health Organization, and the United Nations to coordinate evidence-informed advice on strategic issues. The Group interacted with national research bodies like the Max Planck Society, CNRS, Fraunhofer Society, and funding agencies such as Horizon 2020 and its successor Horizon Europe.

History

The Group was convened following debates at the European Council and recommendations from commissions such as the High-Level Group on the future of the European Research Area and the Group of Chief Scientific Advisors to address gaps identified after crises involving Ebola virus epidemic in West Africa (2013–2016), Zika virus outbreak of 2015–16, and policy challenges highlighted by Brexit negotiations. Its establishment drew on precedents including the Scientific Advice Mechanism reforms, dialogues with the European Academies Science Advisory Council, and lessons from advisory arrangements in the United Kingdom, Germany, and France. Prominent advisors linked to the Group included individuals with affiliations to Royal Society, Accademia Nazionale dei Lincei, and the Leopoldina.

Mandate and Objectives

The Group's mandate encompassed strengthening the interface between scientific communities such as European Molecular Biology Laboratory, CERN, and policymaking bodies including the European Commission directorates-general, to inform policies on topics spanning public health, environment, technology, and innovation. Objectives included improving evidence synthesis practices used by entities like the European Medicines Agency and the European Environment Agency, enhancing preparedness for transnational risks seen in events like the COVID-19 pandemic, and promoting coordination with international initiatives such as the United Nations Framework Convention on Climate Change and the Paris Agreement. It aimed to foster ties with research funders including the European Investment Bank and collaborative programs like the European Innovation Council.

Membership and Structure

Membership drew from senior experts affiliated with organizations such as the Royal Netherlands Academy of Arts and Sciences, Austrian Academy of Sciences, Spanish National Research Council, and major universities like University of Oxford, University of Cambridge, ETH Zurich, and Université PSL. The Group's structure included a Chair, rapporteurs, and thematic working groups modeled after bodies such as the Intergovernmental Panel on Climate Change and the European Food Safety Authority panels. Secretariat support was provided by units within the European Commission and coordinated with networks such as the Global Young Academy and the Academy of Sciences for the Developing World. Liaison mechanisms linked to national ministries including Ministry of Science and Higher Education (Poland), Federal Ministry of Education and Research (Germany), and Ministère de l'Enseignement supérieur, de la Recherche et de l'Innovation (France).

Activities and Reports

The Group produced thematic reports, policy briefs, and methodological guidance influenced by frameworks from the Cochrane Collaboration, World Meteorological Organization, and the International Science Council. Reports addressed topics including pandemic preparedness, digital transformation and artificial intelligence with reference to actors like European Centre for Disease Prevention and Control, data governance debates involving European Data Protection Board, and climate resilience building on work by the Intergovernmental Panel on Climate Change. It organized workshops and stakeholder consultations with participants from European Investment Fund, European Central Bank, civil society groups including Greenpeace, industry representatives such as Siemens, and academic partners like École Polytechnique. Outputs aimed to inform legislative files handled by committees of the European Parliament including the Committee on the Environment, Public Health and Food Safety.

Impact and Criticism

The Group influenced policymaking processes by shaping guidance adopted by the European Commission and informing dialogues in forums such as the G7 and G20 science tracks, while promoting harmonization of advisory practices among agencies like the European Medicines Agency and the European Chemicals Agency. Critics raised concerns echoing debates involving the Lancet and editorial commentary in outlets such as Nature (journal) and Science (journal) about transparency, selection of experts drawn from institutions like Harvard University or Stanford University, and potential conflicts of interest referenced in cases involving industry partnerships with Bayer or GlaxoSmithKline. Additional scrutiny paralleled controversies around advisory bodies in national contexts, for example the Independent SAGE formation in the United Kingdom and advisory restructuring in Italy following public inquiries.

Category:European Union advisory bodies